New research reveals a strong link between persistent brain inflammation and early brain shrinkage in children with MS. These ...

Aviceda Therapeutics has released topline results from its phase 2b study, SIGLEC, evaluating AVD-104 in patients with ...

Worked with leading International and National NGOs for 35 years. Worked with Care India, Care International, Plan India and Plan International among others. Been a lecturer in economics with a ...

As of Tuesday, December 16, Alterity Therapeutics Limited’s ATHE share price has surged by 5.04%, which has investors ...

Aviceda Therapeutics ("the Company" or "Aviceda"), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b ...

A mom was overjoyed when she learned a gene therapy treatment could save her child's life, until she found out no one would ...

The biotech’s lead asset, AVD-104, failed to beat Astellas’ Izervay at slowing the rate of retina lesion growth, the primary ...

Children with MS who have more paramagnetic rim lesions, or chronic inflammation, tend to show faster declines in brain ...

The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...

This video breaks down my complete weekly diet plan for building muscle while staying lean. I’ll take you step by step through my meal prep routine, the exact foods I eat, and how I balance nutrition ...

Successful founders are able to sit with a problem, tolerate uncertainty and persist, writes investor in early-stage ...

Nearly three months after Kevin Rodriguez Zavala died after riding Stardust Racers at Epic Universe, OSCO have closed the ...